Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,705 | 1,061 | 87.6% |
| Consulting Fee | $2,000 | 1 | 11.2% |
| Education | $193.29 | 10 | 1.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37.56 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $3,448 | 132 | $0 (2024) |
| ABBVIE INC. | $2,891 | 183 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,907 | 120 | $0 (2024) |
| Amgen Inc. | $1,363 | 94 | $0 (2024) |
| GlaxoSmithKline, LLC. | $918.40 | 68 | $0 (2024) |
| PFIZER INC. | $849.26 | 86 | $0 (2024) |
| Genentech USA, Inc. | $817.47 | 48 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $772.91 | 39 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $644.41 | 31 | $0 (2019) |
| Lilly USA, LLC | $624.12 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,170 | 111 | ABBVIE INC. ($610.92) |
| 2023 | $1,583 | 105 | AbbVie Inc. ($559.74) |
| 2022 | $3,337 | 90 | Janssen Biotech, Inc. ($2,247) |
| 2021 | $811.09 | 53 | AbbVie Inc. ($394.13) |
| 2020 | $1,028 | 60 | Novartis Pharmaceuticals Corporation ($235.10) |
| 2019 | $2,786 | 188 | Novartis Pharmaceuticals Corporation ($439.57) |
| 2018 | $3,321 | 249 | Genentech USA, Inc. ($413.07) |
| 2017 | $2,900 | 218 | PFIZER INC. ($336.65) |
All Payment Transactions
1,074 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/10/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Immunology | ||||||
| 12/09/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $13.51 | General |
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 11/21/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $10.59 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $4.04 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: Inflammation | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.24 | General |
| Category: Immunology | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $23.73 | General |
| Category: Inflammation | ||||||
| 11/06/2024 | SOBI, INC | KINERET (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,686 | 30,899 | $1.6M | $653,508 |
| 2022 | 35 | 1,904 | 37,628 | $2.2M | $961,353 |
| 2021 | 37 | 2,521 | 41,496 | $2.5M | $1.2M |
| 2020 | 39 | 2,817 | 42,511 | $2.4M | $1.2M |
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9312 | Injection, rituximab, 10 mg | Office | 2023 | 11 | 3,900 | $500,955 | $247,327 | 49.4% |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | Office | 2023 | 27 | 20,401 | $731,172 | $214,266 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 214 | 690 | $101,509 | $59,448 | 58.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 33 | 2,760 | $69,000 | $50,562 | 73.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 189 | 489 | $48,499 | $29,141 | 60.1% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 57 | 185 | $38,800 | $17,721 | 45.7% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 26 | 211 | $21,100 | $4,428 | 21.0% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 53 | 153 | $19,730 | $4,223 | 21.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 31 | 88 | $13,350 | $4,171 | 31.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 206 | 404 | $8,080 | $3,050 | 37.7% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 37 | 37 | $7,955 | $2,253 | 28.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 49 | $5,880 | $1,990 | 33.8% |
| 73100 | X-ray of wrist, 2 views | Office | 2023 | 44 | 88 | $4,400 | $1,894 | 43.0% |
| 73120 | X-ray of hand, 2 views | Office | 2023 | 44 | 88 | $5,280 | $1,865 | 35.3% |
| 77085 | Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment | Office | 2023 | 33 | 33 | $3,300 | $1,606 | 48.7% |
| 85651 | Red blood cell sedimentation rate, to detect inflammation, non-automated | Office | 2023 | 176 | 308 | $7,392 | $1,269 | 17.2% |
| 20550 | Injection into tendon or ligament | Office | 2023 | 20 | 37 | $4,440 | $1,222 | 27.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 105 | 129 | $1,419 | $1,068 | 75.3% |
| J1020 | Injection, methylprednisolone acetate, 20 mg | Office | 2023 | 40 | 233 | $3,029 | $934.82 | 30.9% |
| 73600 | X-ray of ankle, 2 views | Office | 2023 | 17 | 33 | $1,716 | $759.81 | 44.3% |
| 73620 | X-ray of foot, 2 views | Office | 2023 | 18 | 35 | $1,820 | $711.31 | 39.1% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2023 | 18 | 19 | $1,824 | $617.28 | 33.8% |
| 86580 | Skin test for tuberculosis | Office | 2023 | 85 | 88 | $1,936 | $557.50 | 28.8% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 14 | 20 | $1,000 | $426.83 | 42.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 25 | $1,650 | $388.13 | 23.5% |
About Dr. Jon Twining, MD
Dr. Jon Twining, MD is a Rheumatology healthcare provider based in Myrtle Beach, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568492346.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jon Twining, MD has received a total of $17,936 in payments from pharmaceutical and medical device companies, with $2,170 received in 2024. These payments were reported across 1,074 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,705).
As a Medicare-enrolled provider, Twining has provided services to 8,928 Medicare beneficiaries, totaling 152,534 services with total Medicare billing of $4.0M. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Practice Information
- Specialty Rheumatology
- Location Myrtle Beach, SC
- Active Since 07/04/2006
- Last Updated 12/03/2014
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1568492346
Products in Payments
- TREMFYA (Drug) $2,674
- RINVOQ (Biological) $1,562
- COSENTYX (Biological) $1,478
- ACTHAR (Biological) $1,026
- Enbrel (Biological) $987.20
- BENLYSTA (Biological) $805.77
- XELJANZ (Drug) $744.76
- TALTZ (Drug) $584.33
- Humira (Biological) $520.96
- SIMPONI ARIA (Biological) $502.99
- Rituxan (Biological) $423.13
- COSENTYX (Drug) $420.40
- Actemra (Biological) $394.34
- SKYRIZI (Biological) $372.43
- ORENCIA (Biological) $370.08
- Rasuvo (Drug) $344.24
- KEVZARA SARILUMAB INJECTION (Biological) $329.95
- KEVZARA (Biological) $297.10
- Cimzia (Drug) $281.65
- STELARA (Biological) $176.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Myrtle Beach
Douglas Conaway, M.d, M.D
Rheumatology — Payments: $794,524
Dr. David Lazar, M.d, M.D
Rheumatology — Payments: $31,010
Wendy Lee, Md, MD
Rheumatology — Payments: $22,900
Rabih Nayfe, M.d, M.D
Rheumatology — Payments: $18,167
David Chetrit, Md, MD
Rheumatology — Payments: $5,911